25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Author: Lisa Levin | February 19, 2020 09:10am

Gainers

Viveve Medical, Inc. (NASDAQ:VIVE) shares surged 49.3% to $2.03 during Wednesday's pre-market session. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
Streamline Health Solns, Inc. (NASDAQ:STRM) stock surged 30.4% to $1.50.
CytoSorbents, Inc. (NASDAQ:CTSO) stock moved upwards by 9.3% to $5.90.
resTORbio, Inc. (NASDAQ:TORC) stock increased by 8.3% to $1.44.
Genprex, Inc. (NASDAQ:GNPX) stock rose 8.2% to $5.30.
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares moved upwards by 7.5% to $0.85.
Co-Diagnostics, Inc. (NASDAQ:CODX) shares moved upwards by 6.8% to $3.12.
Applied Genetic Tech, Inc. (NASDAQ:AGTC) shares surged 6.8% to $5.77. The most recent rating by Roth Capital, on January 28, is at Buy, with a price target of $25.00.
Brickell Biotech, Inc. (NASDAQ:BBI) shares increased by 6.0% to $1.75.
VIVUS, Inc. (NASDAQ:VVUS) stock increased by 4.7% to $2.66.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares increased by 4.1% to $3.30. The most recent rating by Roth Capital, on January 21, is at Buy, with a price target of $10.00.
Teladoc Health, Inc. (NYSE:TDOC) shares surged 4.0% to $122.00. The most recent rating by Wells Fargo, on February 12, is at Equal-Weight, with a price target of $105.00.
DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) stock moved upwards by 3.9% to $0.57.
ADMA Biologics, Inc. (NASDAQ:ADMA) stock increased by 3.8% to $3.85.
Teligent, Inc. (NASDAQ:TLGT) shares rose 3.7% to $0.56.
Agenus, Inc. (NASDAQ:AGEN) shares moved upwards by 3.6% to $4.04.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) stock surged 3.4% to $1.23.
Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) shares surged 3.2% to $16.87. According to the most recent rating by Wedbush, on January 17, the current rating is at Neutral.
Rockwell Medical, Inc. (NASDAQ:RMTI) stock rose 3.1% to $2.99.
Valeritas Holdings, Inc. (NASDAQ:VLRX) shares moved upwards by 3.1% to $0.30. According to the most recent rating by Oppenheimer, on December 23, the current rating is at Perform.

Losers

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares fell 9.3% to $8.35 during Wednesday's pre-market session.
Tocagen, Inc. (NASDAQ:TOCA) stock fell 4.0% to $0.52.
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock decreased by 3.6% to $0.24.
Vaxart, Inc. (NASDAQ:VXRT) stock declined 3.6% to $1.06.
Bausch Health Companies, Inc. (NYSE:BHC) shares declined 2.6% to $27.35. The most recent rating by Morgan Stanley, on February 12, is at Overweight, with a price target of $32.00.